The Cancer Genome Atlas (TCGA) dataset also showed that KRAS mutations were identified in 40.8% of CRC patients (218 out of 534), with G12D (n = 58) being the most common mutation subtype, followed by G12V (n = 49) and G13D (n = 37)22. This evidence concerns the gene KRAS and colorectal carcinoma.